Please join us in welcoming Dr. Sudhir Borgonha to the FARF team as Translational Science Director. In this role, Sudhir will lead development of FA translational science by working with academic and industry partners to pursue clinical research opportunities to better understand and treat FA. He will manage translational projects including the development of a clinical registry and tissue bank. Sudhir is a physician researcher with over 15 years of experience leading early stage projects and companies. Most recently, as the Medical Director at Strand Genomics, he was instrumental in developing customized gene panels in rare diseases and cancer, including launching a liquid biopsy test. He oversaw clinical reporting in collaboration with clinicians across the globe for over 5,000 patients per year, of which over a 1,000 were in rare diseases. He is a graduate of St. John’s Medical College, Bangalore and the Sloan School of Management, MIT. Sudhir is passionate about integrating emerging technologies into medicine. He is an aspiring writer and still has mixed feelings about why Bob Dylan won the Nobel prize in literature and Philip Roth didn’t.
News
Dr. Sudhir Borgonha Joins FARF as Translational Science Director
Jun 13th, 2018
Categories: Announcements
Related News
Oct 4th, 2024
The 36th Annual Fanconi Anemia (FA) Scientific Symposium and Adult Retreat took place in Charlotte, North Carolina in September 2024, and brought together researchers, clinicians, advocates, individuals with FA and community members from across the globe. This year’s theme, “It Takes...
Announcements
Dec 11th, 2024
This virtual meeting is an opportunity for individuals diagnosed with Fanconi Anemia Neurological Syndrome (FANS) and their families to gather, share experiences, and find mutual support for navigating FANS. Registration is required and participants must speak English as interpretation is...
Announcements
Jul 9th, 2024
On May 24th, 2024, the FA Europe Network hosted its inaugural pan-European scientific meeting at the historic Saint-Louis Hospital in Paris, marking a significant milestone in international collaboration for Fanconi anemia (FA).
Announcements